Forbes: Drug Truths
SEPTEMBER 18, 2023
At a time when the opportunities for discovering and developing new medicines is the greatest in our history, we will be doing less. What we really should be doing is investing more in order to generate new medicines thus reducing downstream healthcare costs.
Science Daily: Pharmacology News
SEPTEMBER 1, 2023
A new study finds that farmers in India have adapted to warming temperatures by intensifying the withdrawal of groundwater used for irrigation. If the trend continues, the rate of groundwater loss could triple by 2080, further threatening India's food and water security. Reduced water availability in India due to groundwater depletion and climate change could threaten the livelihoods of more than one-third of the country's 1.4 billion residents and has global implications.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
BioPharma Drive: Drug Pricing
SEPTEMBER 5, 2023
The FDA-approved therapy, called Palforzia, was little used, leading Nestle to abandon a business it had secured in a $2.6 billion deal three years ago.
Drug Hunter
SEPTEMBER 18, 2023
A First-in-Class TRPA1 Antagonist Overcomes Toxicity Hurdles to Become Cough Candidate Genentech’s GDC-6599 is the first oral TRP Ankyrin 1 (TRPA1) antagonist to reach Ph. IIa ( NCT05660850 ) for chronic cough after preclinical studies and a Ph. I trial showed it was well-tolerated, in contrast to prior molecules. The transient receptor potential (TRP) family of ion channels has been the subject of intensive drug discovery efforts due to their critical role in the development and progression of
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Drugs.com
SEPTEMBER 27, 2023
WEDNESDAY, Sept. 27, 2023 -- Ozempic, a type 2 diabetes drug that has increasingly been used to help with weight loss, will now be labeled as having the potential to block intestines. The U.S. Food and Drug Administration recently made the label.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Forbes: Drug Truths
SEPTEMBER 11, 2023
But, make no mistake – the IRA will have a major impact on biopharma R&D and, as a result, fewer important medicines will be available.
Science Daily: Pharmacology News
SEPTEMBER 28, 2023
For decades, fish-eating killer whales in the Pacific Northwest have been observed harassing and even killing porpoises without consuming them —- a perplexing behavior that has long intrigued scientists.
BioPharma Drive: Drug Pricing
SEPTEMBER 11, 2023
The HER3-targeting treatment could become the next antibody-drug conjugate to emerge from Daiichi Sankyo’s laboratories, after the AstraZeneca-partnered Enhertu.
BioPharma Drive: Drug Pricing
SEPTEMBER 19, 2023
AIRNA is one of several biotechs to debut plans for target alpha-1 antitrypsin deficiency in recent years, with competitors such as AlveoGene, Wave Life Sciences and Arrowhead Pharmaceuticals.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
BioPharma Drive: Drug Pricing
SEPTEMBER 14, 2023
Since 2019, Generate has raised nearly $700 million in private financing and has now brought a monoclonal antibody into Phase 1 testing.
BioPharma Drive: Drug Pricing
SEPTEMBER 25, 2023
Agency scientists flagged numerous issues with Brainstorm’s stem cell treatment ahead of a high-profile Wednesday meeting of expert FDA advisers.
BioPharma Drive: Drug Pricing
SEPTEMBER 29, 2023
The biotech is expanding cuts it announced a few months ago after the EMA decided against renewing a conditional clearance for its drug Translarna.
Drugs.com
SEPTEMBER 20, 2023
WEDNESDAY, Sept. 20, 2023 -- Bats have an extraordinary ability to avoid cancer and handle infections, and researchers now think they might know why.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
BioPharma Drive: Drug Pricing
SEPTEMBER 12, 2023
Arialys Therapeutics launched Tuesday with $58 million in funding from a group of life sciences investors that includes Johnson & Johnson’s venture arm.
BioPharma Drive: Drug Pricing
SEPTEMBER 5, 2023
The announcement marks progress for Beam after trial delays, and is the first time in the U.S. that a patient has received a base editing treatment.
Science Daily: Pharmacology News
SEPTEMBER 21, 2023
Reducing CO2 levels in the atmosphere will take more than cutting emissions -- we will also need to capture and store the excessive volumes of already-emitted carbon. A team of plant scientists argue that arid lands such as deserts could be one answer to the carbon-capture problem.
BioPharma Drive: Drug Pricing
SEPTEMBER 6, 2023
Jane Grogan, an industry veteran who worked at Genentech for over 15 years, will take over the role starting Oct. 2. She’ll fill a seat that's lacked a permanent replacement since the departure of Al Sandrock.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
BioPharma Drive: Drug Pricing
SEPTEMBER 27, 2023
The Swiss drugmaker is restocking its pipeline by buying into preclinical Ionis medicines for Alzheimer’s and Huntington’s diseases.
Drugs.com
SEPTEMBER 20, 2023
WEDNESDAY, Sept. 20, 2023 -- Cardiac rehabilitation is a key part of recovery from a heart attack, helping to prevent another, perhaps more severe one. About 800,000 people in the United States have a heart attack every year, about one-quarter of.
Drugs.com
SEPTEMBER 22, 2023
FRIDAY, Sept. 22, 2023 -- Researchers have found a gene mutation linked to esophageal cancer, which could lead to better prevention and treatment strategies. Investigators from Case Western Reserve University in Ohio found the mutation, potentially.
Drugs.com
SEPTEMBER 22, 2023
FRIDAY, Sept. 22, 2023 – New research suggests some newer diabetes treatments may not be as beneficial for Black patients, after earlier drug trials included small numbers of non-white people. Whether the medications -- called sodium-glucose.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Drugs.com
SEPTEMBER 20, 2023
WEDNESDAY, Sept. 20, 2023 -- Another diabetes drug maker is taking legal action against businesses in several states, alleging that they’re “fraudulently claiming” that their compounded products are the same as its medication.
BioPharma Drive: Drug Pricing
SEPTEMBER 8, 2023
Shape uses machine learning and high throughput screening to identify new AAV capsids in ways the company’s CEO compares to the generative AI tools Midjourney and DALLE-2.
Drugs.com
SEPTEMBER 18, 2023
MONDAY, Sept. 18, 2023 -- Emergency medicine doctors someday might rely on consultation from artificial intelligence (AI) programs like ChatGPT to help them quickly and accurately diagnose patients’ ailments. A new study found that ChatGPT.
Drugs.com
SEPTEMBER 18, 2023
MONDAY, Sept. 18, 2023 -- Over 3 million American children now take medication for attention-deficit/hyperactivity disorder (ADHD), but new research shows medication errors have spiked nearly 300% in the past two decades for these kids. The increase.
Drugs.com
SEPTEMBER 14, 2023
THURSDAY, Sept. 14, 2023 -- An oral vaccine for COVID-19 appears to produce the sort of immune response that could quickly stamp out a developing infection, according to results from a small-scale primate study. Some monkeys given an experimental.
Drugs.com
SEPTEMBER 15, 2023
FRIDAY, Sept. 15, 2023 -- Good oral health is one of the keys to healthy aging, but a sobering new study shows that many U.S. nursing home residents have significant dental issues. Close to two in every 10 residents have missing teeth, about 8%.
Drugs.com
SEPTEMBER 13, 2023
WEDNESDAY, Sept. 13, 2023 -- Using both tobacco and marijuana is tied to significantly higher odds for depression and anxiety, a new study suggests. Among nearly 54,000 U.S. adults, those who used both substances experienced anxiety or depression.
Drugs.com
SEPTEMBER 8, 2023
FRIDAY, Sept. 8, 2023 -- Receiving an organ transplant can be a nerve-wracking, if lifesaving, affair, said Dr. Joaquin Brieva, a kidney transplant recipient. “Within two days of my transplant, my kidney function was back to normal, but then.
Expert insights. Personalized for you.
265 
Let's personalize your content